Showing results (71-80 of 115) with videos related to
Sort By:
Pageof 12
Applied Health Economics and Health Policy|March 31, 2016
Economic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve ProsthesesManal H El-Hamamsy, Gihan H Elsisi, Randa Eldessouki, et al.Population Health Metrics|January 1, 2020
Preventing type 2 diabetes mellitus in Qatar by reducing obesity, smoking, and physical inactivity: mathematical modeling analysesSusanne F Awad, Martin O'Flaherty, Katie G El-Nahas, et al.Journal of Global Health|November 2, 2019
Forecasting the impact of diabetes mellitus on tuberculosis disease incidence and mortality in IndiaSusanne F Awad, Peijue Huangfu, Houssein H Ayoub, et al.Microorganisms|June 2, 2021
Subclinical Mastitis in Selected Bovine Dairy Herds in North Upper Egypt: Assessment of Prevalence, Causative Bacterial Pathogens, Antimicrobial Resistance and Virulence-Associated GenesAhmed H Abed, Ahmed M S Menshawy, Mohamed M A Zeinhom, et al.International Journal of Biological Macromolecules|July 17, 2025
Biodegradable surface-modified bacterial cellulose/phage-based biosensor for ultrasensitive and low-level electrochemical detection of Escherichia coli O157:H7 in food matricesWajid Hussain, Xiaohan Yang, Huan Wang, et al.Biosensors|October 25, 2024
Ultrasensitive Electrochemical Detection of <i>Salmonella typhimurium</i> in Food Matrices Using Surface-Modified Bacterial Cellulose with Immobilized Phage ParticlesWajid Hussain, Huan Wang, Xiaohan Yang, et al.Plos One|October 28, 2021
A systematic review of interventions to promote physical activity in six Gulf countriesElizabeth A Nash, Julia A Critchley, Fiona Pearson, et al.BMJ Open Diabetes Research & Care|August 3, 2024
Impact of mitigating obesity, smoking, and physical inactivity on type 2 diabetes mellitus burden in Oman: insights from mathematical modelingAsalah Alareeki, Susanne F Awad, Adhra Al-Mawali, et al.European Journal of Neurology|March 16, 2026
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have FailedJessica Ailani, Messoud Ashina, Susanne F Awad, et al.Pain and Therapy|April 17, 2026
Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL TrialAmaal J Starling, David Kudrow, Neha Kapur, et al.Pageof 12